STOCK MARKETS

Why is Applied Aerospace and Defense stock climbing today?

2 min readInvesting.com
Why is Applied Aerospace and Defense stock climbing today?

Applied Aerospace and Defense Inc stock rose 2.1% in pre-open trading after a flurry of analyst initiations from major Wall Street firms spotlighted the newly public defense manufacturer’s long-term growth potential.

The most impactful of these came from Baird, which assigned an Outperform rating and a $30 price target — the highest on the Street — based on 25 times its 2028 EBITDA estimate, citing what it described as Cold War 2.0 era dynamics underpinning sustained defense spending growth.

Several more firms joined with constructive views: RBC Capital initiated at Outperform with a $24 target anchored on 19.5 times estimated 2028 adjusted EBITDA of $230 million, while Stifel launched coverage at Buy with a $24 target, pointing to a backlog exceeding $1 billion that it said supports an organic revenue compound annual growth rate of approximately 14% through 2028.

Wolfe Research also started at Outperform with a $23 target, noting the company’s heritage tracing back over 100 years through the combination of Applied Aerospace Structures and PCX Aerosystems.

Morgan Stanley offered a more measured Equalweight rating at a $23 target, reflecting the stock’s demanding post-IPO valuation.

The broader U.S. equity market provided little directional support today, with the S&P 500 essentially flat, the Dow Jones marginally lower, and the Nasdaq also slightly in the red — underscoring that AADX’s pre-market move is driven entirely by company-specific catalysts rather than macro tailwinds.

The defense sector more broadly continues to benefit from elevated government spending priorities, a constructive backdrop that several of the initiating analysts cited as a multi-year structural tailwind for specialized manufacturers like Applied Aerospace.

Taken together, the convergence of five high-profile initiations — four of them bullish — arriving shortly after the company’s June IPO created a meaningful re-rating catalyst, helping shares recover from a session low of $18.37 and trade back above the $20 IPO price. With Baird’s $30 target implying roughly 43% upside from current levels, the analyst activity has given investors a fresh framework for valuing a company that, while still unprofitable, generated $522 million in trailing revenue and holds a backlog that analysts broadly view as a reliable growth engine.